Ignite Creation Date:
2024-05-06 @ 4:12 PM
Last Modification Date:
2024-10-26 @ 2:06 PM
Study NCT ID:
NCT04913948
Status:
COMPLETED
Last Update Posted:
2023-04-13
First Post:
2021-03-03
Brief Title:
Assessing the Mother-to-infant Transmission Capabilities of COVID-19 Infection Among Pregnant Women in Ontario Canada
Sponsor:
Organization:
Ottawa Hospital Research Institute
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITHOUT_DNA
Bio Spec Description:
Should residual samples ie maternal serum umbilical cord serum amniotic fluid breast milk placental tissue frozen and fixed remain after the purposes of the primary outcomes samples will be retained for 10 years for future related REB approved studies
Enrollment Count:
217
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 75984 |
Who Masked List: